Two of Regenstrief Institute’s leaders are sharing their expertise in artificial intelligence and data infrastructure at a workshop hosted by Brazil’s National Institute of Science and Technology in Scientific Assisted Medicine in Sao Paulo, Brazil.

Regenstrief’s Vice President for Research, Eneida Mendonca, M.D., PhD, will speak Thursday, Oct. 17 and Dr. Eneida MendoncaFriday, Oct. 18, about the current research landscape around artificial intelligence in natural language processing. Dr. Mendonca is a pioneer in employing natural language processing to improve health and healthcare delivery. Her research focuses on language-driven approaches to support decision making, exploiting semantic methods to extract data from patients records, and improving infrastructure for research.

Umberto Tachinardi, M.D., Regenstrief Institute’s chief information officer, will discuss the challenges in building data infrastructure to support precision medicine and learning health systems. Dr. Tachinardi has successfully developed and implemented health informatics technologies in organizations of all sizes. Before coming to Regenstrief, he was responsible for building and operating University of Wisconsin Health’s translational research resources, which included data warehouses and new functions in the electronic health record systems. Umberto Tachinardi, Regenstrief Institute

The workshop is aimed at researchers, teachers and students interested in discussing aspects of data modeling, simulation, visualization and analysis and machine learning.

The workshop organizer, the National Institute of Science and Technology in Scientific Assisted Medicine, was created by the Brazilian government to conduct research and development in computer science and its applications in medicine. It consists of 31 associate laboratories, 14 of which are based in seven different countries, including the United States. Drs. Mendonca and Tachinardi are originally from Brazil and have conducted research through the National Institute of Science and Technology in Scientific Assisted Medicine.

 

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Oct 15, 2019 • News
Acceptance and commitment therapy may ease fear of recurrence in cancer survivors
Acceptance and commitment therapy (ACT) shows promise for treating fear of cancer recurrence in women who have survived breast cancer. The first of its kind study by researchers from Regenstrief Institute, Indiana University, Butler University and West Virginia University School of Medicine, published in Cancer, found that cancer survivors who received ACT showed significantly larger…
Continue Reading >
Oct 10, 2019 • News
Regenstrief researcher briefs FDA on need for patient identity management
Patient identity management is a gaping hole in the American electronic healthcare system, one that needs to be addressed to improve the quality of real-world data according to Regenstrief Institute research scientist Shaun Grannis, M.D. He was one of several experts participating in a recent conference in Washington, D.C. to inform the U.S. Food and…
Continue Reading >